The neurologist at Orlando Health discussed findings from an analysis of cladribine tablets in patients aged 50 years and older with relapsing multiple sclerosis presented at CMSC 2026. [WATCH TIME: 7 minutes]
Amy Gutierrez, MD, FAAN
Advertisement
Neurologist at Orlando Health.
Articles by Amy Gutierrez, MD, FAAN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson Disease
2
Atogepant Gains European Approval as Acute and Preventive Migraine Therapy
3
Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCS
4
SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study Update
5